Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas

Clinical trial NCT01721577 · TERMINATED

Trial details

NCT number: NCT01721577
Sponsor: Rush University Medical Center
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Gliosarcoma Anaplastic Astrocytoma Anaplastic Oligodendroglioma Anaplastic Oligoastrocytoma Anaplastic Ependymoma

Start date: 2012-12-01
Primary completion: 2015-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.